Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · VAISHALI

Vaishali Pharma Ltd

HealthcarePharmaceuticals & Biotechnology₹94 cr market cap
₹7.10 ▼ -1.11% today As of 19 Nov 2026
52-week low ₹4.8852-week high ₹9.69

-25.9% from the 52-week high · +47.1% above the low

Vaishali Pharma Ltd. is a healthcare company, which engages in the marketing of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2017-08-22. The firm is engaged in dealing in pharmaceutical ingredient, pharmaceutical formulations, surgical products, herbal and nutraceutical products, veterinary supplements operating in domestic and export market. In domestic markets, it is engaged in contract manufacturing and trading of active pharmaceuticals ingredient's (APIs) and supply of API's for export captive consumption. In export markets, it is engaged in manufacturing and export of pharmaceutical formulations; manufacturing and export of surgical products; manufacturing and export of veterinary products; and manufacturing and export of herbal and nutraceuticals products. Its product categories include API, formulation brands, formulations, herbal, nutraceuticals, oncology, surgical and veterinary, among others. The firm markets approximately 400 products in domestic and APIs has a product portfolio of more than 1,000 products for the overseas market.

The short version. Vaishali Pharma Ltd reported revenue of ₹30 crore for Sep 2026, down 9.1% from a year earlier. Net profit was ₹2 crore (up 100.0% year on year). Return on equity was 6.0% in Mar 2026. Promoter holding was 31.61% in Sep 2026, up 5.29 points over 8 quarters.

1 · The price

How has the stock traded?

Vaishali Pharma Ltd trades 25.9% below its 52-week high and 47.1% above its 52-week low.

Change over period: —

1M-4.8%
3M-13.0%
6M+3.6%
1Y-24.6%

2 · The business

Is it growing?

Sales, year on year-9.1%

Sep 2026 revenue of ₹30 cr.

Profit, year on year+100.0%

Sep 2026 net profit of ₹2 cr.

Net margin6.8%

3.3 pts higher than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025
Revenue3023272533
Net profit22011
Net margin %6.86.81.45.33.5
EPS (₹)0.160.120.030.10.11

Annual

FY2026
Revenue109
Net profit4
Net margin %3.8
EPS (₹)0.32

3 · The quality

How well does it turn capital into profit?

Return on equity was 6.0% in Mar 2026; debt to equity is 0.27.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %6.0———
Return on capital %9.8———
EBITDA margin %7.1———
Net margin %3.7———

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.27
Interest cover3.7x
Current ratio2.34
P/E ratio9.5

4 · The owners

Who holds it, and are they adding?

Promoter holding31.61%

Up 5.29 pts over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter26.3226.3226.3226.3231.6131.6131.6131.61+5.29
FII000000000
DII000000000
Public73.6873.6873.6873.6868.3968.3968.3968.39-5.29

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for Vaishali Pharma Ltd are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about Vaishali Pharma Ltd

What is the Vaishali Pharma Ltd share price?

Vaishali Pharma Ltd (VAISHALI) last closed at ₹7.10, down 1.11% on the day. Its 52-week range is ₹4.88 to ₹9.69.

What is the market cap of Vaishali Pharma Ltd?

Vaishali Pharma Ltd has a market capitalisation of about ₹94 crore. Its price-to-earnings ratio is 9.5.

How are Vaishali Pharma Ltd's latest results?

Vaishali Pharma Ltd reported revenue of ₹30 crore for Sep 2026, down 9.1% from a year earlier. Net profit was ₹2 crore (up 100.0% year on year). Return on equity was 6.0% in Mar 2026. Promoter holding was 31.61% in Sep 2026, up 5.29 points over 8 quarters.

Who owns Vaishali Pharma Ltd?

As of Sep 2026, shareholding was: Promoter 31.61%, Public 68.39%.

How many mutual funds hold Vaishali Pharma Ltd?

0 mutual fund schemes held Vaishali Pharma Ltd in October 2026. That compares with 0 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 15 Oct 2024 · Stock Split From Rs.10/- to Rs.2/-
  • 15 Oct 2024 · Bonus issue 1:1
  • 17 Oct 2019 · Bonus issue 3:5

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.